125I-TA99

N/A

Report date: 2022/06/14 20:00:40
NME

Base Information

Drug Name125I-TA99
Drug Alias Name125I-TA99125I-TA-99
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosinase-related protein 1 inhibitors
TargetsTyrosinase-related protein 1
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMemorial Sloan Kettering Cancer Center
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A